ADC2021-long
  • Program
    • Program 2023
  • Accreditation 2023
    • Accreditation 2023
    • COI Information
  • Scholarships – Case Submissions
  • Exhibitors and Sponsors
    • ADC 2023 Prospectus
    • Exhibitor and Sponsor Registration
    • ADC 2023 Exhibitors
  • Submit Your Abstract
    • Submit Your Abstract
  • Program Organizers
Menu
  • Program
    • Program 2023
  • Accreditation 2023
    • Accreditation 2023
    • COI Information
  • Scholarships – Case Submissions
  • Exhibitors and Sponsors
    • ADC 2023 Prospectus
    • Exhibitor and Sponsor Registration
    • ADC 2023 Exhibitors
  • Submit Your Abstract
    • Submit Your Abstract
  • Program Organizers

Thyroid-stimulating hormone and chronic kidney disease

Annual Dialysis Conference > Posters > Adult > Thyroid-stimulating hormone and chronic kidney disease
Adult
January 28, 2021January 12, 2022 By mimhav

(1) CUISSS west island (2) Kinesiology Department (3) Radiology Department 1042 2021 Adult Canada McGill University McGill University Health Centre Montreal Pointe Claire Quebec
Previous
Transition of a Home Hemodialysis Program to the Tablo System
Transition of a Home Hemodialysis Program to the Tablo System
Next
Longitudinal body composition changes due to peritoneal dialysis using multifrequency bioelectrical impedance analysis
Longitudinal body composition changes due to peritoneal dialysis using multifrequency bioelectrical impedance analysis

Presented in cooperation with

Contact

314-516-8419
Conferences@mimh.edu

  • Program
    • Program 2023
  • Accreditation 2023
    • Accreditation 2023
    • COI Information
  • Scholarships – Case Submissions
  • Exhibitors and Sponsors
    • ADC 2023 Prospectus
    • Exhibitor and Sponsor Registration
    • ADC 2023 Exhibitors
  • Submit Your Abstract
    • Submit Your Abstract
  • Program Organizers